PPIDT00207
Drug Information
| Name | Telavancin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB06402 |
| Type | small molecule |
| Indication | For the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria like methicillin-susceptible or -resistant Staphylococcus aureus, vancomycin-susceptible Enterococcus faecalis, and Streptococcus pyogenes, Streptococcus agalactiae, or Streptococcus anginosus group. Also for the treatment of adult patients with hospital-acquired bacterial pneumonia (HAP) and ventilator-associated bacterial pneumonia (VAP), known or suspected to be caused by susceptible isolates of Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant S. aureus). |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Intravenous |
|
| Injection, powder, for solution | Intravenous |
250 mg
|
| Injection, powder, for solution | Intravenous |
750 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
15 mg/1mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
250 mg/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
750 mg/1
|
| Powder, for solution | Intravenous |
250 mg / vial
|
| Powder, for solution | Intravenous |
750 mg / vial
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | Q15822 | CHRNA2 | Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens | agonist | Link |
| target | P32297 | CHRNA3 | Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens | agonist | Link |
| target | P34998 | CRHR1 | Corticotropin-releasing factor receptor 1 | Homo sapiens | antagonist | Link |